These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12053153)

  • 1. Danazol therapy for thrombocytopenia in patients with myelodysplastic syndromes.
    Viniou N; Plata E; Terpos E; Variami E; Meletis J; Vaiopoulos G; Loukopoulos D; Chatzidimitriou G; Yataganas X
    Acta Haematol; 2002; 107(4):234-6. PubMed ID: 12053153
    [No Abstract]   [Full Text] [Related]  

  • 2. Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome.
    Chan G; DiVenuti G; Miller K
    Am J Hematol; 2002 Nov; 71(3):166-71. PubMed ID: 12410570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases.
    Wattel E; Cambier N; Caulier MT; Sautière D; Bauters F; Fenaux P
    Br J Haematol; 1994 May; 87(1):205-8. PubMed ID: 7947249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen therapy for patients with lower-risk myelodysplastic syndrome and significant cytopenia: a retrospective study.
    Choi EJ; Lee JH; Park HS; Lee JH; Seol M; Lee YS; Kang YA; Jeon M; Woo JM; Kang H; Lee KH
    Br J Haematol; 2019 Oct; 187(1):e4-e7. PubMed ID: 31368111
    [No Abstract]   [Full Text] [Related]  

  • 5. Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy.
    Hebbar M; Kaplan C; Caulier MT; Wattel E; Morel P; Wetterwald M; Bauters F; Fenaux P
    Br J Haematol; 1996 Jul; 94(1):112-5. PubMed ID: 8757517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danazol for lupus thrombocytopenia.
    Marino C; Cook P
    Arch Intern Med; 1985 Dec; 145(12):2251-2. PubMed ID: 4074040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danazol therapy in myelodysplastic syndromes.
    Pozzato G; Franzin F; Moretti M; Campanacci L
    Haematologica; 1992; 77(1):96. PubMed ID: 1398293
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic efficacy of danazol in myelodysplastic syndromes.
    Marini B; Bassan R; Barbui T
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1481-9. PubMed ID: 3181270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danazol and myelodysplastic syndromes.
    Kornberg A; Yona R; Iuklea S; Kaufman S
    Ann Intern Med; 1986 Mar; 104(3):445-6. PubMed ID: 3946991
    [No Abstract]   [Full Text] [Related]  

  • 10. Danazol in the treatment of myelodysplastic syndromes.
    Buzaid AC; Garewal HS; Lippman SM; Durie BG; Katakkar SB; Greenberg BR
    Eur J Haematol; 1987 Oct; 39(4):346-8. PubMed ID: 3319676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome.
    Arber C; Buser A; Heim D; Gratwohl A; Tichelli A; Passweg JR
    Eur J Haematol; 2006 Mar; 76(3):255-7. PubMed ID: 16451398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.
    Gauchan D; Shaaban H; Gedeon D; Maroules M
    Ann Hematol; 2014 Oct; 93(10):1777-8. PubMed ID: 24554304
    [No Abstract]   [Full Text] [Related]  

  • 13. Danazol therapy in myelodysplasia.
    Cines DB; Cassileth PA; Kiss JE
    Ann Intern Med; 1985 Jul; 103(1):58-60. PubMed ID: 4003989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danazol therapy for cyclic thrombocytopenia.
    Rocha R; Horstman L; Ahn YS; Mylvaganam R; Harrington WJ
    Am J Hematol; 1991 Feb; 36(2):140-3. PubMed ID: 2012064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Danazol treatment of myelodysplastic syndromes.
    Stadtmauer EA; Cassileth PA; Edelstein M; Abrahm J; Schreiber AD; Nowell PC; Cines DB
    Br J Haematol; 1991 Apr; 77(4):502-8. PubMed ID: 1827346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of myelodysplastic syndromes with danazol].
    Aviles A; García LD; Romero N; Tripp F; González-Llaven J
    Arch Invest Med (Mex); 1988; 19(1):73-7. PubMed ID: 3228341
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.
    Kantarjian H; Fenaux P; Sekeres MA; Becker PS; Boruchov A; Bowen D; Hellstrom-Lindberg E; Larson RA; Lyons RM; Muus P; Shammo J; Siegel R; Hu K; Franklin J; Berger DP
    J Clin Oncol; 2010 Jan; 28(3):437-44. PubMed ID: 20008626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of rituximab in platelet transfusion refractoriness in a multi-transfused patient with myelodysplastic syndrome.
    Yu QH; Shen YP; Ye BD; Zhou YH
    Platelets; 2015; 26(2):195-6. PubMed ID: 23634876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus and refractory cytopenia: successful outcome with danazol.
    Marwaha V; Kumar A; Grover R; Tiwari S; Chaudhary VP
    Natl Med J India; 2004; 17(1):54-5. PubMed ID: 15115238
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet associated IgG may be related with thrombocytopenia in patients with myelodysplastic syndromes.
    Gilli SC; de Souza Medina S; de Castro V; Fernandes LG; Saad ST
    Leuk Res; 2012 May; 36(5):554-9. PubMed ID: 22129476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.